Hester Biosciences Ltd.

NSE: HESTERBIO | BSE: 524669 | ISIN: INE782E01017 | Industry: Pharmaceuticals
| Falling Comet
1486.6000 -28.30 (-1.87%)
NSE Jan 14, 2026 15:31 PM
Volume: 6,344
 

1486.60
-1.87%

Hester Biosciences Ltd 1QFY17 result update

BOB Capital Markets Ltd.
Hester Biosciences Ltd. posted robust growth in 1QFY17 with revenue growth of 22.8%/6.9% YoY/QoQ, respectively, to Rs 301mn led by 21.6%/41% growth in poultry segment/Large animal segment. EBITDA for the quarter grew by 31%/9.8% YoY/QoQ respectively to Rs 107mn with the expansion in EBITDA margins by 222/94bps YoY/QoQ to 35.5% mainly due to shift in product mix, better inventory management, credit control and lower financing cost.
Hester Biosciences has lost -32.16% in the last 1 Year
More from Hester Biosciences Ltd.
Recommended